Sorry, you need to enable JavaScript to visit this website.

DEPO-SUBQ PROVERA 104® (medroxyprogesterone acetate injectable suspension) References

15. REFERENCES

  1. Li CI, Beaber EF, Tang MCT et al. Effect of Depo-Medroxyprogesterone Acetate on Breast Cancer Risk among Women 20 to 44 years of Age. Cancer Research 2012; 72:2028-2035.
  2. Paul C, Skegg DCG, Spears GFS. Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer. Br Med J 1989; 299:759-62.

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for DEPO-SUBQ PROVERA 104®